The Association of Cancer Care Centers (ACCC) supports its diverse community of multidisciplinary professionals through education and advocacy efforts that identify practical solutions for the complex changes and challenges involved in the delivery of quality cancer care.
Board members play a critical role in shaping the future of oncology care delivery, ensuring that the Association remains responsive to the real-world needs of our members and the patients we serve.
Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.
Each year, the NCCN State Oncology Society Forum is thoughtfully organized to foster meaningful collaboration and forge common bonds to advance dignity and fair access to cancer care. In this blog, Sean T. McCarson shares key insights from stakeholders across the oncology policy landscape at this year's meeting.
The latest issue of Oncology Issues features key insights from the inaugural ACCC Leadership Summit, strategies to adjust to rising patient volumes and workforce strain, advanced practice leadership models, and more.
In the third in a series of multidisciplinary consensus-building roundtables, ACCC and its partners explored ways to bridge the gap between community oncology programs and authorized treatment centers offering CAR T for patients with multiple myeloma.
